Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators (Acta Neuropathologica Communications, (2023), 11, 1, (79), 10.1186/s40478-023-01569-y)

2Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], the authors reported incorrect information in the ‘Acknowledgements’ section. The first part of the ‘Acknowledgements’ section originally read: Work was supported by Ministerio de Ciencia e Innovación and FEDER funds: CP21/00116 and PI22/01171 to RG. The sentence should read: This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project “CP21/00116 and PI22/0117” and co-funded by the European Union to RG. The original article [1] has been updated.

Cite

CITATION STYLE

APA

Segura-Collar, B., Hiller-Vallina, S., de Dios, O., Caamaño-Moreno, M., Mondejar-Ruescas, L., Sepulveda-Sanchez, J. M., & Gargini, R. (2023, December 1). Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators (Acta Neuropathologica Communications, (2023), 11, 1, (79), 10.1186/s40478-023-01569-y). Acta Neuropathologica Communications. BioMed Central Ltd. https://doi.org/10.1186/s40478-023-01600-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free